<DOC>
	<DOC>NCT01143948</DOC>
	<brief_summary>Liver disease is an important cause of death in type 2 diabetes. In the population-based Verona Diabetes Study cirrhosis was the fourth leading cause of death and accounted for 4.4% of diabetes-related deaths. In another prospective cohort study , cirrhosis accounted for 12.5% of deaths in patients with diabetes. In Egypt hepatitis C virus the commonest of cirrhosis here has a prevalence of 9.8% in the population with the greatest burden over national health care bills. Patients with cirrhosis &amp; type 2 diabetes mellitus are always showing up in all hospital wards without a clear consensus of best management of their hyperglycemia.</brief_summary>
	<brief_title>Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial</brief_title>
	<detailed_description>Best management of hyperglycemia in non-intensive care unit Cirrhotic patients with type 2 diabetes by different insulin regimens either sliding scale regular insulin or basal bolus insulin using NPH &amp; regular insulin or Glargine &amp; Glulisine.</detailed_description>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Hospitalized type 2 Diabetes Mellitus with liver cirrhosis Entry blood glucose (fasting or random) greater than 180 mg% Type 1 Diabetes Mellitus Pregnancy Steroids: prednisone greater than 7.5mg/day or equivalent Serum Creatinine &gt; 3 mg/dl Patients in intensive care units.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Cirrhosis</keyword>
	<keyword>Insulin</keyword>
	<keyword>Inpatient</keyword>
</DOC>